Clinical trial
Prospective Evaluation of Artificial Intelligence ECG With Consumer-Facing ECG Devices for Detection of Hypertrophic Cardiomyopathy and Distinction From Athlete's
NCT06290570 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of Artificial Intelligence ECG With Consumer-Facing ECG Devices for Detection of Hypertrophic Cardiomyopathy and Distinction From Athlete's
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- May 7, 2024
- Completion date
- December 31, 2026
- Enrollment
- 183 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypertrophic cardiomyopathy